• 11776 Citations
  • 64 h-Index
1982 …2024
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where David Perlin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Echinocandins Medicine & Life Sciences
caspofungin Medicine & Life Sciences
Candida Medicine & Life Sciences
Aspergillus fumigatus Medicine & Life Sciences
Proton-Translocating ATPases Medicine & Life Sciences
Candida albicans Medicine & Life Sciences
Mutation Medicine & Life Sciences
Candida glabrata Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1987 2024

Multiple Drug Resistance
Infection
Pharmaceutical Preparations
Toxicology
Antibodies
Gram-Negative Bacterial Infections
Multiple Drug Resistance
Infection
Pharmaceutical Preparations
Toxicology
Echinocandins
Candida glabrata
Pharmaceutical Preparations
Candida
Cell Wall

Center to develop therapeutic countermeasures to high-threat bacterial agents

Ebright, R., Dartois, V., Freundlich, J., Alland, D., Connell, N., Perlin, D., Brady, S., Lu, M. I. N. & Bartizal, K.

National Institutes of Health

4/25/1411/30/19

Project: Research project

National Institute of Allergy and Infectious Diseases (U.S.)
Drug Discovery
Anti-Bacterial Agents
Pharmaceutical Preparations
Phloroglucinol
Triazoles
Aspergillus fumigatus
Aspergillosis
Aspergillus
Invasive Pulmonary Aspergillosis

Research Output 1982 2019

Adipose tissue regulates pulmonary pathology during TB infection

Ayyappan, J. P., Ganapathi, U., Lizardo, K., Vinnard, C., Subbian, S., Perlin, D. & Nagajyothi, J. F., Mar 1 2019, In : mBio. 10, 2, e02771-18.

Research output: Contribution to journalArticle

Open Access
Mycobacterium tuberculosis
Adipose Tissue
Tuberculosis
Pathology
Lung
3 Citations (Scopus)

A novel, drug resistance-independent, fluorescence-based approach to measure mutation rates in microbial pathogens

Shor, E., Schuyler, J. & Perlin, D. S., Jan 1 2019, In : mBio. 10, 1, e00120-19.

Research output: Contribution to journalArticle

Open Access
Mutation Rate
Drug Resistance
Fluorescence
Candida glabrata
Mutation
3 Citations (Scopus)

Applying host disease status biomarkers to therapeutic response monitoring in invasive aspergillosis patients

Zhao, Y., Nagasaki, Y., Paderu, P., Sugrue, M. W., Leather, H. L., Wingard, J. R. & Perlin, D. S., Jan 1 2019, In : Medical mycology. 57, 1, p. 38-44 7 p.

Research output: Contribution to journalArticle

Aspergillosis
Biomarkers
Leukemia
Haptoglobins
Hematopoietic Stem Cell Transplantation
1 Citation (Scopus)

Beyond tissue concentrations: Antifungal penetration at the site of infection

Zhao, Y., Prideaux, B., Baistrocchi, S., Sheppard, D. C. & Perlin, D. S., Apr 1 2019, In : Medical mycology. 57, p. S161-S167

Research output: Contribution to journalReview article

Infection
Pharmaceutical Preparations
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Morbidity
Mortality
3 Citations (Scopus)

Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa

Papp-Wallace, K. M., Zeiser, E. T., Becka, S. A., Park, S., Wilson, B. M., Winkler, M. L., D'Souza, R., Singh, I., Sutton, G., Fouts, D. E., Chen, L., Kreiswirth, B. N., Ellis-Grosse, E. J., Drusano, G. L., Perlin, D. S. & Bonomo, R. A., Jul 19 2019, In : The Journal of infectious diseases. 220, 4, p. 666-676 11 p.

Research output: Contribution to journalArticle

Open Access
Fosfomycin
Pseudomonas aeruginosa
Stem Cells
Therapeutics
Mutation Rate